Latest Regulatory Progress News

HeraMED advances AI-driven maternity care partnerships and strengthens its US commercial team, navigating policy uncertainties while progressing its global expansion and funding strategies.

Sipa Resources is poised to begin a heritage survey at its Crown Gold Project in Western Australia, a critical step ahead of its maiden aircore drilling program scheduled for September. This move follows extensive groundwork to refine drill targets and signals continued momentum in the company’s 2025 gold exploration campaign.

Ballymore Resources has reported exceptional high-grade gold intersections at its Dittmer Project, alongside government grants to accelerate exploration and a key mining lease approval recommendation.

Enova Mining reports promising exploration results across its Brazilian and Australian projects, highlighting high-grade rare earth element assays and advancing metallurgical testing and regulatory approvals.

4DMedical has landed a $10 million strategic investment from Pro Medicus, aimed at accelerating its commercial growth and advancing its CT – VQ™ technology towards FDA clearance in the US.

Larvotto Resources delivers a robust Definitive Feasibility Study for its Hillgrove Antimony-Gold Project, backed by $165 million in fresh funding and regulatory approvals, targeting production in Q2 2026.

Aspire Mining Limited has refined its Ovoot Coking Coal Project development plans to reduce upfront capital expenditure, progressing towards mining commencement in Q4 2025 amid positive market feedback and advancing infrastructure contracts.

Northern Minerals reports strong progress on its Browns Range Heavy Rare Earths Project with key regulatory approvals, promising exploration results, and near-completion of its Definitive Feasibility Study amid tightening global supply.

Medical Developments International (MVP) reports positive operating cash flow in H2 FY25, driven by strong Penthrox sales and strategic distribution shifts in Europe. The company eyes further growth amid regulatory progress and efficiency gains.

HALO Technologies reports $3.54 million in Q2 revenue with rising subscription income, progressing UK expansion pending FCA approval, and a $6.75 million capital raise nearing completion.

Beetaloo Energy Australia Limited has completed a $35 million capital raise and successfully finished hydraulic stimulation of its Carpentaria-5H well, setting the stage for production expected in 2026. Traditional Owner consent and strong liquidity underpin the company’s next development phase.

Neurotech International reports encouraging Phase I human pharmacokinetic results for its pediatric cannabinoid drug NTI164, alongside published clinical trial data in Rett Syndrome and key regulatory progress in the US and Australia.